Freedom of information (FOI) releases from OUH

This is a disclosure log of Oxford University Hospitals NHS Foundation Trust's responses to freedom of information (FOI) or environmental information regulations (EIR) requests that might be of wider public interest.

If you can't find the information you're looking for, you can make a new FOI request.

Filters

Clear filters

  • Keywords filters

  • Year filters

  • Month filters

99 disclosures

  1. Urology Theatre Productivity and Adult Male Circumcision (Innovation Gap)

    In light of the NHS 'Further Faster' elective recovery targets and the successful regional adoption of stapler-assisted circumcision (ZSR/CircCurer) at trusts such as Liverpool and Wigan, please provide the following data for the period 2024/25 and 2025/26 to date:

    Adoption of Innovations

    1. Does the Trust currently utilize stapler-assisted devices (e.g., ZSR/CircCurer) for adult therapeutic circumcision?

    2. If not, has the Trust conducted a formal productivity review of this technology in the last 12 months to meet elective recovery throughput targets?

    Theatre Productivity

    3. What is the average "Entry to Exit" theatre time currently allocated for an adult circumcision performed via traditional suture methods?

    4. What percentage of these procedures are performed under Local Anaesthetic (LA) in an outpatient/procedure room setting, versus General Anaesthetic (GA) in a main theatre suite?  

    Waiting List Performance

    5. What is the current median waiting time (in weeks) for an adult medically indicated circumcision from "Decision to Treat"?

    6. How many patients are currently on the urology elective list for this specific procedure?

    Efficiency Metrics

    7. Has the Trust calculated the potential theatre capacity gains if adult circumcisions were moved from General Anaesthetic to a 10-minute Local Anaesthetic stapler-assisted model?

     

    Published: 21 August 2026

  2. Rare Disease Patients and Treatment

    REQUEST: Q1. How many total patients has the trust seen within the latest 24 months of available data (for any reason), with a recorded diagnosis of Dravet Syndrome (DS)


    Q2. Of total DS patients, how many have been treated with Epidyolex (Cannabidiol) in the last 12 months?


    Q3. Of total DS patients, how many have been treated with Fintepla (Fenfluramine) in the last 12 months?


    Q4. How many total patients has the trust seen within the latest 24 months of available data (for any reason), with a recorded diagnosis of Lennox-Gasteau Syndrome (LGS)?


    Q5. Of total LGS patients, how many have been treated with Epidyolex (Cannabidiol) in the last 12 months?


    Q6. Of total LGS patients, how many have been treated with Fintepla (Fenfluramine) in the last 12 months?


    Q7. How many adult (aged 18+) patients has the trust seen within the latest 24 months of available data (for any reason), with a recorded diagnosis of Dravet Syndrome (DS)


    Q8. How many adult (aged 18+) patients has the trust seen within the latest 24 months of available data (for any reason), with a recorded diagnosis of Lennox-Gasteau Syndrome (LGS)

    Published: 21 August 2026

  3. Diagnosis of Alzheimer’s Disease

    1. I would be grateful if you could send the most recent planning document(s) for the diagnosis and treatment of Alzheimer's Disease, whether these are from the Trust, Integrated Care Board (ICB), or the region. I am particularly interested in planning documents that cover lumbar punctures (CSF) and Blood Biomarker testing. Please provide - As per previous response August 2025, the Neurology service is not aware of such document.

    Please provide

    2. To what extent are there plans for service improvement of diagnosing Alzheimer's Disease?

    3. Are the plans for service improvement of diagnosing Alzheimer's Disease related to:

    4. Which of the following services does the Trust have in place in preparation for increased service delivery for Alzheimer's Disease?
    Related to administration of lumbar punctures - please choose from below
    Related to Blood Biomarker testing
    Budget
    People
    Training
    Clinic space / capacity
    Governance arrangements

    5. How many lumbar puncture procedures to test for Alzheimer's Disease were performed in the last three-month period for which data are available?

    Number of procedures
    Number of lumbar punctures

    6. Please provide the number of BBM tests for Alzheimer's Disease conducted over the last three-months, regardless of whether they were carried out within your organisation or sent to an external pathology laboratory.

    Number of tests TOTAL Number of tests NHS patients Number of tests Private Sector Number of Blood Biomarker tests


    7. Which of the following biomarker tests were used to detect Alzheimer's Disease?

    Yes / No

    8. Please provide a list of the full names of other Trusts or other organisations, to which the Trust refers samples for pTau181 and pTau217 immunoassay testing for Alzheimer's Disease?

    Full name of Trust or organisation(s)

    9. How many pTau181 immunoassay tests were conducted to test for Alzheimer's Disease in the last three-months?

    Number of tests TOTAL Number of tests NHS patients Number of tests Private Sector:
    Number of pTau181 tests:


    10. Is pTau181 testing for Alzheimer's Disease linked to, or conducted in conjunction with, clinical trials?

    11. How many pTau181 immunoassay tests were conducted for Alzheimer's Disease as part of a clinical trial?

    12. How many pTau217 immunoassay tests were conducted to test for Alzheimer's Disease in the last three-months?

    Number of tests TOTAL Number of tests NHS patients Number of tests Private Sector
    Number of pTau217 tests

    13. Is pTau217 testing for Alzheimer's Disease linked to, or conducted in conjunction with, clinical trials?

    14. How many pTau217 immunoassay tests were conducted for Alzheimer's Disease as part of a clinical trial?

    Published: 20 August 2026

  4. MRI & CT AI adoption

    Please see below my FOI request regarding radiology AI software. With the pressures on the NHS, particularly at this time of year, we are keen to understand whether your NHS Trust is embracing AI solutions.

    1) a)How many MRI scanners do you have within the Trust?

    b)How many of these MRI scanners are outsourced or provided by a 3rd party?

    2) How many of these MRI scanners are more than 10 years old?

    3) How many of the MRI scanners have AI software installed?

    4) How many of these MRI scanners doesn"t have AI installed?

    5) Please complete the table below for your Trust:

    MRI Manufacturer (AI Software)

    Total number of MRIs with AI software

    Total number of MRIs without AI software Siemens (Deep Resolve) GE Healthcare (Sonic DL) Philips (SmartSpeed) Other (Canon, Esaote, United Imaging)

    6) How many CT scanners do you have within the Trust?

    7) How many of these CT scanners are more than 10 years old?

    8) Does your Trust utilise AI software for lung cancer screening - Yes/No?

    * If yes, please can you name the software?

    9) Does your Trust purchase X-Ray AI software - Yes/No?

    10) If yes, which AI software does your Trust utilise for:

    * Chest X-ray screening?

    * Breast X-ray (mammography or Tomosynthesis)?

    * Fracture detection?

    Published: 20 August 2026

  5. Surgical Workforce Data

    Please provide the following information for your Trust/hospital site(s) for the most recent complete 12-month period available (please state the exact start and end dates used). If your data are only available at Trust level (not site level), please provide Trust-level figures and state this explicitly.

    Please report data separately for each of the following specialties (use the exact labels below):
    1. Cardiothoracic Surgery
    2. General Surgery (including breast, colorectal, endocrine, upper GI, lower GI, and transplant—kidney, liver, pancreas)
    3. Neurosurgery
    4. Oral & Maxillofacial Surgery
    5. ENT / Otolaryngology
    6. Paediatric Surgery
    7. Plastic Surgery
    8. Trauma & Orthopaedic Surgery
    9. Urology
    10. Vascular Surgery

    If a specialty is not provided at your Trust/hospital site(s), please record 0 for that specialty and note “not provided”.

    1) Workforce (headcount)

    For each specialty listed above, please provide current number of employed at the trust:
    • Number of Consultant surgeons (substantive/headcount)

    • Number of SAS surgeons (headcount) (i.e., Specialty Doctor and Specialist grades)

    Please provide headcount (not WTE). If you can only provide WTE, please state that clearly.

    2) Population served

    Please provide the total population served by your Trust/hospital (the figure you use for planning/catchment), and specify the source/definition used (e.g., “ICS population”, “catchment population”, etc.).

    3) Surgical admissions activity

    Please provide the total number of admissions (elective + emergency combined) to all surgical specialties provided, stratified across each specialty for the same 12-month period. Period: 01-07-2025 to 30-06-2026

    Published: 20 August 2026

  6. Unwanted Fire Alarm Signals (UFAS)

    I would like to request the following information for the period 1 January 2023 - 31 December 2025:

    1. Total number of Unwanted Fire Alarm Signals (UFAS)

    2. Number attributed to kitchen appliances

    3. Number attributed to toasters specifically

    4. Number of evacuations triggered by kitchen-related alarms

    5. Estimated cost of fire service call-outs related to kitchen appliance incidents

    6. Any internal risk assessments referencing kitchen appliance-related fire signals If possible, please provide the data in spreadsheet format.

    Published: 20 August 2026

  7. New cancer diagnosis

    Can you please provide all new cancer diagnoses for 0–24-year-olds who live within the postcodes NN17, NN18. This is to cover the term: 1st January 2025 to the current date of this request. One total figure will suffice.

    Published: 19 August 2026

  8. Lung Cancer Consultants / Doctors cover protocol.

    1-The total number of Consultants clinic appointments in oncology/radiotherapy that were delayed or cancelled, highlighting unfilled appointments or vacancies due to staff leave (e.g., annual leave, sickness and Cancer Consultants reducing their clinic activity) between June 2nd 2023 and August 28th 2023. 


    Staffing Ratios: Planned vs.actual Oncologist/Radiographers clinic appointments ratios for this date.
    Shift Cover:Whether specific clinic appointments were covered by regular staff,bank staff,or agency cover.


    2-Copies of the department's contingency or holiday cover policies/rota management plans that were active during this timeframe.


    3-Meeting minutes or internal risk assessments discussing oncology/radiotherapy staffing levels, shortages, or holiday cover during this period.
    Please provide this information in an email.

    Published: 19 August 2026

  9. Fraudulent Job Applications

    Please provide:

    1. The number of conditional employment offers withdrawn because the Trust discovered that an applicant had supplied deliberately false, falsified or fraudulent information.

    2. The number of individuals who had already begun working for the Trust when such information was discovered. For both questions, please break the figures down by:

    (a) the type of false information, for example qualifications, professional registration, employment history or references; and

    (b) the type of professional or position concerned, for example doctor, nurse, physiotherapist, dietitian, healthcare assistant or administrator. If either requested breakdown is unavailable, please provide the closest breakdown held, such as job title, occupation or staff group.

    3. For Question 2, Please provide the FIVE longest periods across the three financial years between an individual beginning work and the false information being discovered, expressed in years and days (for example, seven years and four days). If these durations are not held in years and days, please provide them in the closest available unit of measurement. If there were fewer than five such cases, please provide the duration for every case.

    Please assign each case to the financial year in which the false information was discovered, regardless of when the application was submitted or the employment began.

    Published: 18 August 2026

  10. OPCS-4 procedures carried out in your hospitals

    I am seeking information relating to procedures recorded under OPCS-4 code H44.1.

    Please provide, for each financial year (or calendar year if more readily available) from 2016 to 2026, the following:

    1. The number of H44.1 procedures performed.

    2. The total number of bed days associated with patients undergoing H44.1 procedures.

    3. The total clinical cost associated with these procedures, where recorded and available. If possible, please provide the above data: *Broken down by sex. *Broken down by age group (for example: under 20, 20-29, 30-39, 40-49, 50-59, 60-69, 70-79, 80+).

    I would be grateful if the information could be supplied in CSV format. Suggested column headings are: OPCS4_Code, Year, Age_Group, Sex, Number_of_Procedures, Bed_Days, Clinical_Cost

    Published: 18 August 2026